Compare DLTR & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLTR | PODD |
|---|---|---|
| Founded | 1986 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.8B | 22.1B |
| IPO Year | 1995 | 2007 |
| Metric | DLTR | PODD |
|---|---|---|
| Price | $123.01 | $304.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 19 |
| Target Price | $113.29 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 3.7M | 765.6K |
| Earning Date | 12-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.45 |
| Revenue | ★ $18,960,900,000.00 | $2,521,800,000.00 |
| Revenue This Year | $12.76 | $32.55 |
| Revenue Next Year | $5.97 | $20.39 |
| P/E Ratio | ★ $23.07 | $88.24 |
| Revenue Growth | ★ 156.37 | 27.11 |
| 52 Week Low | $61.80 | $230.05 |
| 52 Week High | $125.79 | $354.88 |
| Indicator | DLTR | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 74.53 | 40.94 |
| Support Level | $107.44 | $303.20 |
| Resistance Level | $111.95 | $317.34 |
| Average True Range (ATR) | 4.41 | 13.12 |
| MACD | 1.53 | -2.82 |
| Stochastic Oscillator | 87.40 | 3.14 |
Dollar Tree operates discount stores across the United States and Canada, with over 8,800 shops under its namesake banner. About 50% of Dollar Tree's sales in fiscal 2024 were consumables (including food, health and beauty, and cleaning products), around 45% variety items (including toys and homewares), and 5% seasonal items. Dollar Tree sells most of its merchandise at the $1.25 price point and positions its stores in well-populated suburban markets. The retailer has agreed to sell Family Dollar (with about 7,000 stores) to private equity investors for $1 billion.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.